Analyst I, Analytical Development (12 month fixed term)

Replimune-2; Abingdon; On-site; GBP 26,000 - 34,000; Full time

Job summary

Replimune seeks an Analyst I, AD to perform routine analytical testing in support of AD, PD and QC projects. Based at Milton Park (UK), it requires 5 days on-site and is a fixed-term 12-month contract.

Duties include PCR, ELISA, chromatography and cell-based assays; support method development and product characterization; prepare reagents; maintain equipment; ensure GMP and SOP adherence. A Biological Sciences BSc is preferred.

Qualifications

• Biological sciences background preferred.
• Interest and aptitude for biological sciences.
• Able to manage time and work independently, including in a small team.

Responsibilities

• Perform PCR, ELISA, chromatography and cell-based analytical tests.
• Support analytical method development and product characterization.
• Prepare laboratory reagents and controls for routine testing and development.
• Maintain calibration and verification of laboratory equipment.
• Ensure GMP compliance and SOP adherence.

Skills

Biological sciences

Time management

Independent working

Communication

Education

Biological Sciences BSc degree

Tools

Microsoft Word

Excel

Outlook

Job description

Overview

Replimune’s mission is to revolutionize cancer treatment with therapies designed to activate a powerful and durable full-body anti-tumor response, boldly transforming cancer care because patient’s lives depend on it.

At Replimune, we live by our values:

United: We Collaborate for a Common Goal.

Audacious: We Are Bold.

Dedicated: We Give Our Full Commitment.

Candid: We Are Honest With Each Other.

People are at the center of everything we do, and when it comes to our employees, we make it personal. With a deep sense of purpose, a strong and evolving culture, a competitive and forward-looking total rewards program, everyone at Replimune has a unique opportunity to impact on the lives of patients, caregivers and themselves.

Join us, as we reshape the future.

Summary of job description:

The Analyst I, AD performs routine analytical testing to support AD, Process Development (PD), Research and Quality Control (QC) projects. The Analyst I, AD, also provides support for AD characterization and method development projects. The Analyst I, AD, is also responsible for supporting the day-to-day operation of the Analytical Development (AD) laboratories. This role is fixed-term for a period of 12 months.

• This position is based in our Milton Park (UK) location and typically has a 5-day on-site expectation.

Key responsibilities:

• Key performer of PCR, ELISA, chromatography and cell-based analytical tests to support PD, AD, Research and QC testing.
• Provide support for performing analytical method development and product characterisation projects.
• Prepare laboratory chemical reagents and biological assay standards and controls for use in routine testing and development projects.
• Oversee and perform internal periodic maintenance, calibration and verification of laboratory equipment.
• Perform general laboratory housekeeping tasks, including maintaining stock levels of laboratory consumables.
• Operate in accordance with Good Manufacturing Practice (GMP), company procedures and health and safety practices.
• Author, update and adhere to equipment and method SOP’s as required.

Other responsibilities

• Perform review of assay sheets, lab books and GMP documentation.
• Training team members in equipment usage and maintenance.

Educational requirements:

• Biological Sciences BSc degree preferred.

Experience and skill requirement:

• A demonstrated interest and an aptitude for biological sciences.
• A self-motivated individual, with good time management and able to work in an organised manner.
• An ability to work independently and as part of a small team, with effective communication and an ability to work flexibly to meet varying workloads.
• Good IT skills in core applications e.g. Microsoft Word, Excel, Outlook.

About Replimune

Replimune Group, Inc., headquartered in Woburn, MA, was founded in 2015 with the mission to transform cancer treatment by pioneering the development of a novel portfolio of oncolytic immunotherapies. Replimune’s proprietary RPx platform is based on a potent HSV-1 backbone intended to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The RPx platform is designed to have a unique dual local and systemic activity consisting of direct selective virus-mediated killing of the tumor resulting in the release of tumor derived antigens and altering of the tumor microenvironment to ignite a strong and durable systemic response. The RPx product candidates are expected to be synergistic with most established and experimental cancer treatment modalities, leading to the versatility to be developed alone or combined with a variety of other treatment options. For more information, please visit www.replimune.com.

We are an Equal Opportunity Employer.